ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,601Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 337

$756K Total Retail Price of All Prescriptions

Rank: 26 out of 337

527 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 527 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 527 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 14,415 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
WARFARIN SODIUM 1,067 991 1 11
SIMVASTATIN 841 737 2 1
LISINOPRIL 591 499 3 2
LEVOTHYROXINE SODIUM 569 470 4 5
FUROSEMIDE 524 459 5 8
AMLODIPINE BESYLATE 466 423 6 3
METOPROLOL TARTRATE 410 380 7 6
ATENOLOL 359 330 8 10
CITALOPRAM HBR 303 296 9 17
DONEPEZIL HCL 294 293 10 22
CHLORTHALIDONE 290 268 11 117
METFORMIN HCL 284 246 12 12
OMEPRAZOLE 267 211 13 4
ATORVASTATIN CALCIUM 260 227 14 7
LOVASTATIN 237 213 15 24
ALENDRONATE SODIUM 221 215 16 19
LANTUS 210 190 17 49
SERTRALINE HCL 209 185 18 18
TRAZODONE HCL 194 174 19 16
QUETIAPINE FUMARATE 192 176 20 61
HYDROCODONE-ACETAMINOPHEN 178 107 S3 21 13
MIRTAZAPINE 170 157 22 27
HYDROCHLOROTHIAZIDE 165 143 23 9
PRAVASTATIN SODIUM 159 142 24 14
POTASSIUM CHLORIDE 153 128 25 62
TAMSULOSIN HCL 149 138 26 25
NOVOLOG 142 124 27 106
QUINAPRIL HCL 138 136 28 50
GABAPENTIN 136 112 29 20
LOSARTAN POTASSIUM 132 125 30 15
RAMIPRIL 129 113 31 80
OXYCODONE HCL 115 18 S2 32 63
CLOZAPINE 115 52 32 94
DIVALPROEX SODIUM 106 94 34 101
RANITIDINE HCL 105 66 35 30
ADVAIR DISKUS 104 91 36 44
VENLAFAXINE HCL ER 103 96 37 86
CARVEDILOL 102 102 38 73
DIGOXIN 102 96 38 58
RISPERIDONE 100 100 40 72
LACTULOSE 98 81 41 105
POLYETHYLENE GLYCOL 3350 97 72 42 47
GLIPIZIDE 97 95 42 45
PAROXETINE HCL 96 84 44 46
ALBUTEROL SULFATE 89 88 45 131
TRAMADOL HCL 87 71 46 32
ZETIA 82 82 47 89
NAMENDA 82 81 47 35
SEROQUEL 80 67 49 107
FLUTICASONE PROPIONATE 80 66 49 34
PROAIR HFA 78 59 51 38
ALLOPURINOL 76 50 52 28
SPIRIVA 74 66 53 43
CYMBALTA 73 57 54 59
LIPITOR 72 62 55 33
PHENYTOIN SODIUM EXTENDED 72 39 55 150
PREDNISONE 71 71 57 40
LIDODERM 68 49 58 82
DIOVAN 68 68 58 26
KLOR-CON M20 66 66 60 65
ENALAPRIL MALEATE 64 51 61 37
GLYBURIDE 64 52 R 61 53
LEVETIRACETAM 64 52 61 112
DOXAZOSIN MESYLATE 61 61 64 68
FLUOCINONIDE 61 61 64 250
OLANZAPINE 61 48 64 108
FINASTERIDE 61 61 64 83
CIPROFLOXACIN HCL 61 48 64 71
ESCITALOPRAM OXALATE 59 59 69 66
CLOPIDOGREL 57 52 70 42
CEPHALEXIN 57 56 70 130
CRESTOR 55 47 72 29
GENERLAC 54 39 73 164
ENULOSE 54 33 73 171
VERAPAMIL ER 52 52 75 77
LEVOFLOXACIN 51 44 76 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 21, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.